
Brilique — ticagrelor 90 mg, tablets, 56 pcs
Brand: AstraZeneca
+ delivery from €40
Brilique. Active ingredient — ticagrelor, 90 mg. Dosage form — orodispersible tablets. Pack size — 56 tablets, 56 unit-dose blisters.
Key information
Full description
Brilique 90 mg is a medicine from the marketing authorisation holder AstraZeneca AB, Sweden, containing ticagrelor in the form of orodispersible tablets. Ticagrelor is an antiplatelet medicine and is used as part of treatment regimens when inhibition of platelet aggregation is required. The specific indications and combination with acetylsalicylic acid are determined by the official package leaflet and the doctor. One tablet contains 90 mg of ticagrelor; the pack contains 56 tablets in unit-dose blisters. The medicine is contraindicated in active pathological bleeding, a history of intracranial haemorrhage and severe hepatic impairment.
Administration
For oral use. The dosing regimen and duration of use are determined by the doctor, taking into account the official package leaflet.
Storage conditions
Store in the original package, out of the reach of children, observing the conditions specified by the manufacturer in the official package leaflet.
Frequently asked questions
What is the active ingredient in Brilique?
Brilique contains ticagrelor.
What dosage form does Brilique come in?
Dosage form: Orodispersible tablets. Strength: 90 mg.
How much is in a pack of Brilique?
The pack contains 56 tablets, 56 unit-dose blisters.
How should Brilique be stored?
Store in the original package, out of the reach of children, observing the conditions specified by the manufacturer in the official package leaflet.
Other strengths and pack sizes
How to order
Tap the button for your preferred messenger. A manager will check availability, confirm the price and ask for your full delivery address.
This information is for reference only. Consult a doctor and read the official package leaflet before use.